Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

LAAO May Be an Option for Anticoagulated AF Patients With Breakthrough Stroke

Todd Neale

September 30, 2025

News Daily News

Top Heart Rhythm News of 2022

Todd Neale

January 05, 2023

News Daily News

LAA Thrombus Explored as Potential Cause of Stroke After TAVR

Todd Neale

January 16, 2017

News Daily News

Does the Watchman LAA Occluder Reduce Bleeding?

L.A. McKeown

November 25, 2015

News Daily News

Latest Watchman Design Appears Safer, More User-Friendly

Yael L. Maxwell

September 16, 2015

News Daily News

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Yael L. Maxwell

July 17, 2015

News Daily News

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Yael L. Maxwell

June 17, 2015

News Daily News

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Caitlin E. Cox

January 28, 2015

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

Identificados los Factores de Riesgo para la Formación de Trombos asociados a los Dispositivos Oclusores Cardíacos en Pacientes con FA

Yael L. Maxwell

June 28, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Jason Kahn

March 05, 2012

Advertisement

LAAO May Be an Option for Anticoagulated AF Patients With Breakthrough Stroke

Top Heart Rhythm News of 2022

LAA Thrombus Explored as Potential Cause of Stroke After TAVR

Does the Watchman LAA Occluder Reduce Bleeding?

Latest Watchman Design Appears Safer, More User-Friendly

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Registry Data Suggest Protection Up to 2 Years With LAA Closure

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

Identificados los Factores de Riesgo para la Formación de Trombos asociados a los Dispositivos Oclusores Cardíacos en Pacientes con FA

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Watchman Works Just as Well Without Warfarin-Protected Transition

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content